2nd Circuit: Relators In Cancer Drug False Claim Case Weren’t ‘Original Sources’
NEW YORK — A panel of the Second Circuit U.S. Court of Appeals on March 28 affirmed dismissal of a whistleblower lawsuit in which two relators alleged that an oncology treatment...To view the full article, register now.
Already a subscriber? Click here to view full article